Success Metrics

Clinical Success Rate
77.8%

Based on 7 completed trials

Completion Rate
78%(7/9)
Active Trials
0(0%)
Results Posted
71%(5 trials)
Terminated
2(18%)

Phase Distribution

Ph early_phase_1
1
9%
Ph phase_4
2
18%
Ph not_applicable
8
73%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
1(9.1%)
Phase 4Post-market surveillance
2(18.2%)
N/ANon-phased studies
8(72.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.0%

7 of 10 finished

Non-Completion Rate

30.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(7)
Terminated(3)
Other(1)

Detailed Status

Completed7
Terminated2
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
77.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (9.1%)
Phase 42 (18.2%)
N/A8 (72.7%)

Trials by Status

terminated218%
withdrawn19%
unknown19%
completed764%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
OTHER
Total Trials
11